Numerous investigations have demonstrated that LOXL2 expression is markedly changed in several cancer types, including lung cancer, aggressive osteosarcoma, pancreatic ductal adenocarcinoma, prostate, colorectal, and breast cancer (19-24). The gene discussed is LOXL2; the disease is cancer.